Loading candles…
Saroja Pharma Ltd, incorporated in 2023 and headquartered in Mumbai, operates primarily as a trader and exporter in the pharmaceuticals and chemical trading industries. The company focuses on trading Thionyl Chloride chemicals and pharmaceutical intermediates. It deals in Active Pharmaceutical Ingredients (APIs), pharma intermediates, and specialty chemicals, sourcing these products from domestic and international markets. Saroja Pharma Ltd supplies its chemical and pharmaceutical products to various industrial sectors, including healthcare and veterinary services. There are no publicly available details about its founders, key management, subsidiaries, or notable projects. The company shares a name similarity with another entity, 'Saroja Pharma Industries India Ltd.'
This page is a live market overview for SAROJA PHARMA INDUS IND L (SAROJA) on the NSE. As a listed security, SAROJA PHARMA INDUS IND L is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SAROJA before placing trades on tick2trade.
As of the latest feed, SAROJA last traded at ₹40.9 on NSE, up ₹0 (0.00%) from the previous close of ₹40.9. Today's session range is ₹0 – ₹0, against a 52-week band of ₹0 – ₹48. Traded volume today stands at — shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for SAROJA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SAROJA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SAROJA PHARMA INDUS IND L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SAROJA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SAROJA option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.